Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies
Med Research · 2025-09 · 1 (2) · 239-256
DOI: 10.1002/mdr2.70020 ↗Abstract
ABSTRACT Pneumoconiosis, caused by exposure to inorganic hazardous materials, is a highly prevalent and severe occupational disease. It is characterized by a progressive inflammatory process and the development of permanent lung fibrosis, which ultimately can lead to respiratory failure and mortality. Ferroptosis is a non‐apoptotic, regulated cell death pathway driven by iron‐of dependent accumulation membrane‐localized lipid peroxides. It acts as a promoting mechanism and participates in the biological processes of pneumoconiosis. Notably, alveolar macrophages, epithelial cells, and endothelial cells exhibit exquisite vulnerability to ferroptosis, highlighting targeting this process as a promising treatment approach for pneumoconiosis. Thus, a comprehensive and in‐depth understanding of the role of ferroptosis in pneumoconiosis is critical to enable the successful clinical translation of ferroptosis‐targeted therapies. In this review, we provide an overview of the recent advancements in understanding ferroptosis in pneumoconiosis, covering molecular mechanisms, regulatory pathways and biological functions. We also summarize the potential applications of ferroptosis inhibition for pneumoconiosis treatment across pulmonary cell populations. We finally discuss the current challenges and future directions of ferroptosis in the treatment of pneumoconiosis.
EUVIMED